Clinical Trial

Analysis of the Role of AIRE in Autoimmune Neurological Diseases Associated With Autoantibodies

Study acronym: NAD-AIRE
Recruiting
View on ClinicalTrials.gov →
Summary
Studying genetic predisposition in autoimmune neurological diseases could help improve diagnostic accuracy and offer new treatment possibilities
Trial Details
NCT Number NCT06941584
Lead Sponsor Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Collaborators: University of Bergen
Conditions AIRE Deficiency
Enrollment 40 participants
Start Date 2024-11-06
Primary Completion 2027-01-06 (estimated)
Study Completion 2027-01-06 (estimated)
Updated on ClinicalTrials.gov 2025-04-24